Facebook
Twitter
LinkedIn
ForwardSGLT2 Inhibitors and Diabetes Management
SPEAKER: Jelyca Ormond, MD
Target Audience
All Physicians
Learning Objectives
- Describe the four pillar approach to diabetes care
- Determine if SGLT2 inhibitors are appropriate for your patient
- Be able to provide education to patients and employ shared decision making to create an appropriate regimen for your patient
Additional Information
The presenter & planning committee members for this activity have disclosed that they have no relevant relationships with commercial or industry organizations. The CME Department has reviewed their disclosure information for the planner(s) and/or committee/faculty for this program and they do not have relationships that present a relevant conflict of interest. Kaiser Permanente does not endorse any brand name products.
The presenter & planning committee members for this activity have disclosed that they have no relevant relationships with commercial or industry organizations (Commercial Interest). The CME Department has reviewed their disclosure information for the planner(s) and/or committee/faculty for this program and they do not have relationships that present a relevant conflict of interest. Kaiser Permanente does not endorse any brand name products.
Kaiser Santa Clara is accredited by the California Medical Association (CMA) to provide continuing medical education for physicians. The Kaiser Santa Clara designates this Live Activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 1.00 AMA PRA Category 1 Credit(s)™
- 1.00 Attendance